---
title: Biohaven Pharma Case Study - 2025 | Echelon
description: Discover how Biohaven Pharma’s bold manager-first coaching strategy fueled a $12B exit. Here's the playbook behind their breakout success.
image: https://go.thinkechelon.com/hubfs/coaching%20strategy%20case%20study_biohaven%20pharma.png
---

# Out-Coaching the Competition

## How Biohaven Pharma Turned Manager Leverage into a $12B Exit 

![Out Coaching the Competition_Biohaven_Pharma_Case Study](https://go.thinkechelon.com/hubfs/Out%20Coaching%20the%20Competition_Biohaven_Pharma_Case%20Study.png "Out Coaching the Competition_Biohaven_Pharma_Case Study")

In 2019, Biohaven Pharma was an underdog. By 2022, it was acquired by Pfizer for $12 billion. The turning point? A bold decision to coach first-line managers, not reps.

*Out-Coaching the Competition: How Biohaven Pharma Turned Manager Leverage Into a $12B Exit *reveals how a focus on first-line manager development drove execution, resilience, and market share. 

Inside this case study, you'll learn how:

![Out Coaching the Competition_Biohaven_Pharma_Case Study](https://go.thinkechelon.com/hs-fs/hubfs/Out%20Coaching%20the%20Competition_Biohaven_Pharma_Case%20Study.png?width=200&height=280&name=Out%20Coaching%20the%20Competition_Biohaven_Pharma_Case%20Study.png)

- How data exposed performance blind spots
- The playbook for scaling execution through first-line managers
- What great coaching actually looks like

This isn’t just a success story. It’s a strategy.

 Download the Case Study

© 2026 Echelon Performance     |   [Privacy Policy](https://go.thinkechelon.com/privacy-policy?hsLang=en)